MindBio's Landmark Phase 2a LSD-Microdosing (MB22001) Clinical Trial Nears Completion
Hi MindBio is pleased to report that dosing is progressing well in its Phase 2a Depression trial using MB22001…
Read issue →MB22001: a titratable form of LSD for take-home Microdosing, will it work in Depression or will we have to pivot?
Hi MindBio is pleased to report that dosing is progressing well in its Phase 2a Depression trial using MB22001…
Read issue →Its Cancer. Though, it's their Depression we are Treating.(B)
Hi Approvals for take-home microdosing, could change everything! You need to see this video Stay Well! JUSTIN HANKA…
Read issue →Its Advanced Stage Cancer. Though, it's their Depression we are Treating. (A)
Hi Approvals for take-home microdosing, could change everything! You need to see this video Stay Well! JUSTIN HANKA…
Read issue →First take-home dosing begins in Phase 2B LSD-Microdosing Trial in Cancer Patients
Hi We've got some uplifting news from MindBio Therapeutics that we couldn't wait to share! Click Here For Video Here's…
Read issue →LSD-Microdosing at home gets MindBio Therapeutics a Nomination
Hi I hope this email finds you well. We are thrilled to announce that MindBio Therapeutics has been nominated for the…
Read issue →New Update on Phase 2a MB22001 Microdosing Trial.
Hi We are thrilled to update you on the recent progress of our Phase 2 LSD-Microdosing for depression clinical trial.…
Read issue →Curious about health AI? Join me in the Lab.
Hi We're thrilled to share a sneak peek into the groundbreaking work happening at Life AI Corp through an exclusive…
Read issue →